Healiva SA

Healiva is a patient-centric Biotech commercialising a portfolio of innovative, personalised and affordable life-enhancing precision medicine for chronic and acute wounds and target key pain-points in the patient care pathway. The end-to-end approach has core enzyme technology and is paired with cell therapies or medical devices. A successful regimen can prevent bone infection, hospitalisation, amputation and even death – allowing patients to re-establish their normal life routines.

Healiva aims to become a “one stop shop” B2B wound care solutions provider with a multifaceted customer base encompassing hospitals, medical practitioners, insurance providers and patients.